90 related articles for article (PubMed ID: 26288297)
1. [Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach].
Krupitsky ЕМ; Kibitov АО; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Kosten Т; Nielsen D; Zvartau EE; Woody D
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4 Pt 2):14-23. PubMed ID: 26288297
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
3. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the cellular composition and of the inflammatory response activity in the lymph nodes of patients with sarcoidosis at different stages of the clinical course and treatment with systemic glucocorticosteroids].
Ніколєнко ДЄ; Бойко ДМ
Wiad Lek; 2017; 70(1):32-37. PubMed ID: 28343190
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
6. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
Ashenhurst JR; Bujarski S; Ray LA
Pharmacol Biochem Behav; 2012 Dec; 103(2):253-9. PubMed ID: 22954510
[TBL] [Abstract][Full Text] [Related]
7. [Translational medicine in Russian cardiology: a new stage or repetition of the past?].
Tereshchenko SN; Zhirov IV; Kochetov AG
Ter Arkh; 2016; 88(9):5-9. PubMed ID: 27735907
[TBL] [Abstract][Full Text] [Related]
8. Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.
Krupitsky E; Zvartau E; Blokhina E; Verbitskaya E; Wahlgren V; Tsoy-Podosenin M; Bushara N; Burakov A; Masalov D; Romanova T; Tyurina A; Palatkin V; Yaroslavtseva T; Pecoraro A; Woody G
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):614-620. PubMed ID: 27436632
[TBL] [Abstract][Full Text] [Related]
9. [Anhedonia, depression, anxiety, and craving in opioid dependent patients stabilized on oral naltrexone or naltrexone implant].
Krupitsky EM; Zvartau EE; Blokhina EA; Verbitskaya EV; Wahlgren VY; Tsoy-Podosenin MV; Bushara NM; Burakov AM; Masalov DV; Romanova TN; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Sulimov GY; Pecoraro A; Woody G
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1. Vyp. 2):26-33. PubMed ID: 29658501
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
11. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
[TBL] [Abstract][Full Text] [Related]
12. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
13. The future of Jungian analysis: strengths, weaknesses, opportunities, threats ('SWOT').
Samuels A
J Anal Psychol; 2017 Nov; 62(5):636-649. PubMed ID: 28994472
[TBL] [Abstract][Full Text] [Related]
14. [The polymorphic markers of АРОВ and APOE genes and the chromosomal region 3q21-q25 are associated with the development of diabetic nephropathy in type 1 diabetes mellitus].
Savostyanov KV; Shestakova MV; Yakunina NY; Vikulova OK; Voronko OY; Chugunova LA; Shamkhalova MS; Dedov II; Nosikov VV
Probl Endokrinol (Mosk); 2005 Jun; 51(3):18-21. PubMed ID: 31627582
[TBL] [Abstract][Full Text] [Related]
15. Emotional Intelligence in Carriers of Different СОМТ, BDNF, DRD2 and HTR2A Genotypes.
Vorobyeva EV; Kovsh EM; Kosonogov VV
Psychol Russ; 2022; 15(2):83-96. PubMed ID: 36699706
[TBL] [Abstract][Full Text] [Related]
16. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
Krupitsky EM; Blokhina EA; Zvartau EE; Verbitskaya VE; Bushara EM; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Burakov AM; Masalov DV; Romanova TN; Grininko AY; Sinha R; Kosten T
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):39-46. PubMed ID: 26525620
[TBL] [Abstract][Full Text] [Related]
17. [The use of different forms of naltrexone in the treatment of opioid dependence].
Krupitskiĭ EM; Zvartau EE; Blokhina EA; Woody G
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 2):66-72. PubMed ID: 22611701
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of the renin-angiotensin system in breast cancer patients.
Fishchuk LE; Gorovenko NG
Exp Oncol; 2013 Jun; 35(2):101-4. PubMed ID: 23828384
[TBL] [Abstract][Full Text] [Related]
19. The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATA-binding protein.
Drachkova I; Savinkova L; Arshinova T; Ponomarenko M; Peltek S; Kolchanov N
Hum Mutat; 2014 May; 35(5):601-8. PubMed ID: 24616209
[TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
Oslin DW; Berrettini W; Kranzler HR; Pettinati H; Gelernter J; Volpicelli JR; O'Brien CP
Neuropsychopharmacology; 2003 Aug; 28(8):1546-52. PubMed ID: 12813472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
